Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix

Oncogene volume 25, pages 3924–3933 (2006)Cite this article

Abstract

Multiple lines of evidence have provided compelling evidence for the existence of a tumor suppressor gene (TSG) on chromosome 7q31.1. ST7 may be the target of this genetic instability but its designation as a TSG is controversial. In this study, we show that, functionally, ST7 behaves as a tumor suppressor in human cancer. ST7 suppressed growth of PC-3 prostate cancer cells inoculated subcutaneously into severe combined immunodeficient mice, and increased the latency of tumor detection from 13 days in control tumors to 23 days. Re-expression of ST7 was also associated with suppression of colony formation under anchorage-independent conditions in MDA-MB-231 breast cancer cells and ST7 mRNA expression was downregulated in 44% of primary breast cancers. Expression profiling of PC-3 cells revealed that ST7 predominantly induces changes in genes involved in re-modeling the extracellular matrix such as SPARC, IGFBP5 and several matrix metalloproteinases. These data indicate that ST7 may mediate tumor suppression through modification of the tumor microenvironment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P et al. (1996). Cancer Res 56: 3808–3813.

  • Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, Menon PM et al. (2005a). J Biol Chem 280: 36483–36493.

  • Barker TH, Framson P, Puolakkainen PA, Reed M, Funk SE, Sage EH . (2005b). Am J Pathol 166: 923–933.

  • Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R . (1992). Lancet 339: 139–143.

  • Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH . (2003). J Clin Invest 111: 487–495.

  • Brown VL, Proby CM, Barnes DM, Kelsell DP . (2002). Br J Cancer 87: 208–211.

  • Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J et al. (2005). Int J Cancer 113: 789–797.

  • Chlenski A, Liu S, Baker LJ, Yang Q, Tian Y, Salwen HR et al. (2004). Cancer Res 64: 7420–7425.

  • Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. (2003). Genome Biol 4: P3.

  • Dong SM, Sidransky D . (2002). Clin Cancer Res 8: 2939–2941.

  • Hughes KA, Hurlstone AF, Tobias ES, McFarlane R, Black DM . (2001). Nat Genet 29: 380–381.

  • Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L et al. (2004). Cancer Res 64: 3037–3045.

  • Kato Y, Tsukuda M, Nagashima Y, Koshika S, Sakai N, Yao M et al. (2005). Int J Oncol 27: 759–768.

  • Katoh M . (2002). Int J Oncol 20: 1247–1253.

  • Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW et al. (1997). Genes Chromosomes Cancer 19: 1–5.

  • Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris AL et al. (2003). Cancer Res 63: 5376–5380.

  • Kruzelock RP, Cuevas BD, Wiener JR, Xu FJ, Yu Y, Cabeza-Arvelaiz Y et al. (2000). Oncogene 19: 6277–6285.

  • Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R . (1995). Clin Cancer Res 1: 1385–1389.

  • Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, Carles J et al. (1999). J Pathol 189: 46–52.

  • Lu C, Xu HM, Ren Q, Ao Y, Wang ZN, Ao X et al. (2003). World J Gastroenterol 9: 2662–2665.

  • Lussier C, Sodek J, Beaulieu JF . (2001). J Cell Biochem 81: 463–476.

  • Moschos SJ, Mantzoros CS . (2002). Oncology 63: 317–332.

  • Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M . (1993). Mol Cell Biol 13: 6036–6043.

  • Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S . (2004). Mol Cell Biol 24: 9630–9645.

  • Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA . (2001). Curr Biol 11: 1805–1809.

  • Paoni NF, Feldman MW, Gutierrez LS, Ploplis VA, Castellino FJ . (2003). Physiol Genomics 15: 228–235.

  • Puolakkainen PA, Brekken RA, Muneer S, Sage EH . (2004). Mol Cancer Res 2: 215–224.

  • Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R, Preissner KT . (1997). Biochem J 324: 311–319.

  • Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD . (1998). J Exp Med 187: 1965–1975.

  • Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE et al. (2002). Am J Pathol 161: 35–41.

  • Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI . (1997). Oncogene 15: 2727–2733.

  • Stanhope-Baker P, Kessler PM, Li W, Agarwal ML, Williams BR . (2004). J Biol Chem 279: 33575–33585.

  • Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM et al. (1995). Cancer Res 55: 4114–4119.

  • Thomas NA, Choong DY, Jokubaitis VJ, Neville PJ, Campbell IG . (2001). Nat Genet 29: 379–380.

  • Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL . (2000). Clin Cancer Res 6: 1140–1149.

  • Vincent JB, Herbrick JA, Gurling HM, Bolton PF, Roberts W, Scherer SW . (2000). Am J Hum Genet 67: 510–514.

  • Vincent JB, Petek E, Thevarkunnel S, Kolozsvari D, Cheung J, Patel M et al. (2002). Genomics 80: 283–294.

  • Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS et al. (2001). Am J Pathol 159: 609–622.

  • Zenklusen JC, Bieche I, Lidereau R, Conti CJ . (1994a). Proc Natl Acad Sci USA 91: 12155–12158.

  • Zenklusen JC, Conti CJ, Green ED . (2001). Nat Genet 27: 392–398.

  • Zenklusen JC, Hodges LC, LaCava M, Green ED, Conti CJ . (2000). Oncogene 19: 1729–1733.

  • Zenklusen JC, Oshimura M, Barrett JC, Conti CJ . (1994b). Oncogene 9: 2817–2825.

  • Zenklusen JC, Thompson JC, Klein-Szanto AJ, Conti CJ . (1995a). Cancer Res 55: 1347–1350.

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ . (1994c). Cancer Res 54: 6370–6373.

  • Zenklusen JC, Weitzel JN, Ball HG, Conti CJ . (1995b). Oncogene 11: 359–363.

  • Zhang JS, Nelson M, McIver B, Hay ID, Goellner JR, Grant CS et al. (1998). Oncogene 17: 789–793.

Download references

Acknowledgements

We thank the staff of the Peter MacCallum Cancer Centre Microarray Facility and Christina Restall for technical assistance. This work was supported by a grant from the Cancer Council of Victoria.

Author information

Authors and Affiliations

  1. VBCRC Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

    Cs-F Hooi, C Blancher, W Qiu, I M Revet, L H Williams & I G Campbell

  2. Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

    M L Ciavarella & W A Phillips

  3. Cancer Biology Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

    R L Anderson

  4. VBCRC Invasion and Metastasis Group, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia

    E W Thompson & A Connor

  5. Department of Pathology, University of Melbourne, Melbourne, Australia

    R L Anderson & I G Campbell

  6. Department of Surgery (St Vincent's Hospital), University of Melbourne, Melbourne, Australia

    E W Thompson, A Connor & W A Phillips

Authors
  1. Cs-F Hooi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Blancher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I M Revet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L H Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M L Ciavarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R L Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E W Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. W A Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. I G Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I G Campbell.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hooi, CF., Blancher, C., Qiu, W. et al. ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix. Oncogene 25, 3924–3933 (2006). https://doi.org/10.1038/sj.onc.1209418

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209418

Keywords

This article is cited by

Search

Advanced search

Quick links